|
Status |
Public on Nov 22, 2011 |
Title |
Proteasome inhibition blocks estrogen-dependent gene transcription by decreasing histone H2B monoubiquitination in human breast cancer cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
The estrogen receptor-alpha (ERα) determines breast cancer cell phenotype and is a prognostic indicator. A better understanding of the mechanisms controlling ERα function may uncover improved strategies for the treatment of breast cancer. Proteasome inhibition was previously reported to regulate estrogen-induced transcription but the mechanisms by which it influences ERα function remain controversial. In this study we investigated the transcriptome-wide effects of the proteasome inhibitor Velcade on estrogen-regulated transcription in MCF7 human breast cancer cells and demonstrate a specific global decrease in estrogen-induced transcription.
|
|
|
Overall design |
This set contains 12 microarray samples. 3 controls, 3 estrogen stimulated, 3 Bortezomib stimulated, 3 Bortezomib + estrogen stimulated
|
|
|
Contributor(s) |
Prenzel T, Begus-Nahrmann Y, Kramer F, Hennion M, Hsu C, Gorsler T, Hintermayr C, Eick D, Kremmer E, Simons M, Beissbarth T, Johnsen SA |
Citation(s) |
21862633 |
|
Submission date |
Jul 25, 2011 |
Last update date |
Aug 13, 2018 |
Contact name |
Frank Kramer |
E-mail(s) |
[email protected]
|
Organization name |
University Medical Center Göttingen
|
Department |
Department of Medical Statistics
|
Street address |
Humboldtallee 32
|
City |
Goettingen |
ZIP/Postal code |
37073 |
Country |
Germany |
|
|
Platforms (1) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
Samples (12)
|
|
Relations |
BioProject |
PRJNA146281 |